Skip to main content
. 2013 Sep 25;2013:404396. doi: 10.1155/2013/404396

Table 2.

Incidence of toxicities in treated patients.

Toxicities Normal no. (%) G1,2 no. (%) G3 no. (%) G4 no. (%)
Haematological toxicity
 Neutropenia 34 (58.6) 16 (27.6) 8 (13.8)
 Febrile neutropenia 40 (69) 15 (25.9) 2 (3.4) 1 (1.7)
 Anemia 20 (34.5) 34 (58.6) 4 (6.9)
 Thrombocytopenia 50 (86.2) 8 (13.8)
Nonhaematological toxicity
 Skin and nail disorders 4 (6.9) 26 (44.8) 11 (19) 17 (29.3)
 Scaling 16 (27.6) 25 (43.1) 9 (15.5) 8 (13.8)
 Stomatitis 30 (51.7) 20 (34.5) 6 (10.3) 2 (3.4)
 Hand-foot syndrom 23 (39.7) 15 (25.9) 6 (10.3) 14 (24.1)
 Erythema 48 (82.8) 10 (17.2)
 Paresis 27 (46.6) 17 (29.3) 10 (17.2) 4 (6.9)
 Paresthesia 20 (34.4) 16 (27.6) 19 (32.8) 3 (5.2)
 Myalgia 41 (70.7) 11 (19) 4 (6.9) 2 (3.4)
 Arthralgia 23 (39.7) 19 (32.8) 13 (22.4) 3 (5.1)
 Nausea 6 (10.3) 36 (62.1) 10 (17.2) 6 (10.3)
 Vomiting 21 (36.2) 25 (43.1) 7 (12.1) 5 (8.6)
 Fluid retention 38 (65.5) 18 (31.1) 2 (3.4)
 Phlebitis 51 (87.9) 4 (6.9) 3 (5.2)
 Any grade 4 event 32 (55%)
 Death 2 (3.4)